CN1146573C - 阿拉伯糖腺嘌呤衍生物 - Google Patents
阿拉伯糖腺嘌呤衍生物 Download PDFInfo
- Publication number
- CN1146573C CN1146573C CNB991089081A CN99108908A CN1146573C CN 1146573 C CN1146573 C CN 1146573C CN B991089081 A CNB991089081 A CN B991089081A CN 99108908 A CN99108908 A CN 99108908A CN 1146573 C CN1146573 C CN 1146573C
- Authority
- CN
- China
- Prior art keywords
- ara
- compound
- derivatives
- virus
- ada
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Abstract
Description
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP177209/98 | 1998-06-24 | ||
JP177209/1998 | 1998-06-24 | ||
JP17720998A JP3619017B2 (ja) | 1998-06-24 | 1998-06-24 | 新規アラビノシルアデニン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1242373A CN1242373A (zh) | 2000-01-26 |
CN1146573C true CN1146573C (zh) | 2004-04-21 |
Family
ID=16027087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB991089081A Expired - Fee Related CN1146573C (zh) | 1998-06-24 | 1999-06-24 | 阿拉伯糖腺嘌呤衍生物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6242429B1 (zh) |
EP (1) | EP0967220B1 (zh) |
JP (1) | JP3619017B2 (zh) |
KR (1) | KR100624050B1 (zh) |
CN (1) | CN1146573C (zh) |
AT (1) | ATE236923T1 (zh) |
DE (1) | DE69906625T2 (zh) |
ES (1) | ES2196676T3 (zh) |
TW (1) | TW564249B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA72912C2 (uk) * | 1999-02-01 | 2005-05-16 | Юніверсіті Оф Вірджінія Патент Фаундейшн | Композиція для лікування запальної реакції |
CN1370170A (zh) * | 1999-05-25 | 2002-09-18 | 宾夕法尼亚州研究基金会 | Dna甲基转移酶抑制剂 |
EP1420021A1 (en) * | 1999-05-25 | 2004-05-19 | The Penn State Research Foundation | DNA Methyltransferase inhibitors |
US7405304B2 (en) | 2002-01-10 | 2008-07-29 | The Penn State Research Foundation | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids |
JP2006502974A (ja) | 2002-05-17 | 2006-01-26 | ニューロジェン コーポレイション | 置換環縮合イミダゾール誘導体:gabaa受容体リガンド |
KR20040036417A (ko) * | 2002-10-25 | 2004-04-30 | 정낙신 | 항암 활성을 갖는 티오뉴클레오시드 유도체 및 이를함유하는 약학적 조성물 |
EP1805196A1 (en) * | 2004-10-15 | 2007-07-11 | AstraZeneca AB | Substituted adenines and the use thereof |
JP5070550B2 (ja) * | 2006-04-13 | 2012-11-14 | 国立大学法人北海道大学 | 抗ヘルペスウイルス活性を有するヌクレオシド誘導体 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5545625A (en) | 1978-09-26 | 1980-03-31 | Ajinomoto Co Inc | 2-methyl-n6-substituted adenine-arabinoside and its preparation |
JPS55160797A (en) * | 1979-05-31 | 1980-12-13 | Ajinomoto Co Inc | Purine nucleoside derivative |
AU575438B2 (en) | 1984-10-26 | 1988-07-28 | Warner-Lambert Company | N6 - substituted deoxyribose analogues of adenosines |
JPS6299395A (ja) | 1985-10-25 | 1987-05-08 | Yamasa Shoyu Co Ltd | 2−アルキニルアデノシンおよび抗高血圧剤 |
AU8276187A (en) | 1986-10-31 | 1988-05-25 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
JPH0723394B2 (ja) | 1986-11-27 | 1995-03-15 | 日本臓器製薬株式会社 | 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
DE3739366A1 (de) * | 1987-04-10 | 1988-10-27 | Boehringer Mannheim Gmbh | Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel |
GB8712745D0 (en) | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
GB2226027B (en) | 1988-12-13 | 1992-05-20 | Sandoz Ltd | Adenosine derivatives,their production and use |
JPH0725785B2 (ja) | 1989-01-11 | 1995-03-22 | 日本臓器製薬株式会社 | アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
DE69123974T2 (de) | 1990-09-25 | 1997-05-07 | Rhone Poulenc Rorer Int | Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen |
HUT61567A (en) | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
US5705491A (en) * | 1992-10-27 | 1998-01-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Adenosine deaminase inhibitor |
-
1998
- 1998-06-24 JP JP17720998A patent/JP3619017B2/ja not_active Expired - Fee Related
-
1999
- 1999-06-22 KR KR1019990023448A patent/KR100624050B1/ko not_active IP Right Cessation
- 1999-06-23 TW TW088110523A patent/TW564249B/zh not_active IP Right Cessation
- 1999-06-23 AT AT99111945T patent/ATE236923T1/de not_active IP Right Cessation
- 1999-06-23 DE DE69906625T patent/DE69906625T2/de not_active Expired - Fee Related
- 1999-06-23 EP EP99111945A patent/EP0967220B1/en not_active Expired - Lifetime
- 1999-06-23 ES ES99111945T patent/ES2196676T3/es not_active Expired - Lifetime
- 1999-06-24 US US09/339,257 patent/US6242429B1/en not_active Expired - Fee Related
- 1999-06-24 CN CNB991089081A patent/CN1146573C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0967220B1 (en) | 2003-04-09 |
JP3619017B2 (ja) | 2005-02-09 |
KR20000006339A (ko) | 2000-01-25 |
DE69906625D1 (de) | 2003-05-15 |
ATE236923T1 (de) | 2003-04-15 |
TW564249B (en) | 2003-12-01 |
CN1242373A (zh) | 2000-01-26 |
JP2000007695A (ja) | 2000-01-11 |
US6242429B1 (en) | 2001-06-05 |
ES2196676T3 (es) | 2003-12-16 |
DE69906625T2 (de) | 2004-02-05 |
KR100624050B1 (ko) | 2006-09-19 |
EP0967220A1 (en) | 1999-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3134402B1 (en) | 4-amino-imidazoquinoline compounds | |
CN1033701C (zh) | 9-(2-羟基乙氧基甲基)鸟嘌呤衍生物的制备方法 | |
US5032583A (en) | 2,N-6-disubstituted adenosines and their antihypertensive methods of use | |
US20010025043A1 (en) | New pharmaceutical active compounds | |
CN1426418A (zh) | 膦酸酯核苷酸化合物 | |
HUT64335A (en) | Process for producing 1,3-oxatiolane-nucleozide analogues and pharmaceutical preparatives containing them | |
JPH07500317A (ja) | 1,3−オキサチオランヌクレオシド類似体 | |
CN1139929A (zh) | 取代的3-亚芳基-7-氮杂羟吲哚化合物及其制备方法 | |
CN1313860A (zh) | 2-(嘌呤-9-基)-四氢呋喃-3,4-二醇衍生物 | |
CN1516590A (zh) | 4′-取代的核苷 | |
JPH05186495A (ja) | 環状オリゴヌクレオチドホスホロチオアート | |
EA015251B1 (ru) | Производные хиназолина и их использование при лечении тромбоцитемии | |
CN1023804C (zh) | 新型炔属、氰基芒霉素/腺苷衍生物的制备方法 | |
CN1048495C (zh) | 四氢吡喃衍生物、其制备方法和含有它们的药物组合物 | |
CN1029968C (zh) | N-杂芳基-嘌呤-6-胺的制备方法 | |
CN1146573C (zh) | 阿拉伯糖腺嘌呤衍生物 | |
CN1179422A (zh) | 新黄酮化合物、制备它们的方法以及含有它们的药物组合物 | |
CN1046334A (zh) | 新的2′-卤代亚甲基、2′-亚乙烯基和2′-乙炔基腺苷衍生物 | |
CN1019495B (zh) | 嘧啶衍生物的制备方法 | |
CN1906196A (zh) | 具有hiv和hcv抗病毒活性的4'-取代的卡波韦-和阿巴卡韦-衍生物以及相关化合物 | |
CN1390228A (zh) | 口服活性a1腺苷受体激动剂 | |
CN1036398C (zh) | 治疗用核苷 | |
CN1047676A (zh) | 具有抗病毒作用的次黄苷和胸苷衍生物盐的制备方法 | |
EP0765322B1 (en) | Indole derivatives as prodrugs of 5-ht1-like receptor agonists | |
JP3068175B2 (ja) | イソチアゾロ〔5,4―b〕ピリジン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CI01 | Publication of corrected invention patent application |
Correction item: Denomination of Invention Correct: Arabia sugar adenine derivatives False: Arabia adenine adenine derivatives Number: 4 Volume: 16 |
|
CI02 | Correction of invention patent application |
Correction item: Denomination of Invention Correct: Arabia sugar adenine derivatives False: Arabia adenine adenine derivatives Number: 4 Page: The title page Volume: 16 |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |